Gilead to license generic version of Sovaldi

September 15, 2014 7:31 PM

4 0

Gilead to license generic version of Sovaldi

Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.

Gilead said Monday that the India-based companies will make a generic version of Sovaldi, also known as sofosbuvir, and another investigational drug for distribution in 91 countries.

Also read: Ohio State attacker was angry about treatment of Muslims, official says

Read more

To category page

Loading...